Standard

The use of agomelatine (Valdoxan) in the treatment of gambling: A pilot study. / Egorov, A.Yu.

In: Neuroscience and Behavioral Physiology, Vol. 47, No. 7, 2017, p. 795–798.

Research output: Contribution to journal › Article › peer-review

Harvard

Egorov, AY 2017, 'The use of agomelatine (Valdoxan) in the treatment of gambling: A pilot study', Neuroscience and Behavioral Physiology, vol. 47, no. 7, pp. 795–798.

APA

Egorov, A. Y. (2017). The use of agomelatine (Valdoxan) in the treatment of gambling: A pilot study. Neuroscience and Behavioral Physiology, 47(7), 795–798.

Vancouver

Egorov AY. The use of agomelatine (Valdoxan) in the treatment of gambling: A pilot study. Neuroscience and Behavioral Physiology. 2017;47(7):795–798.

Author

Egorov, A.Yu. / The use of agomelatine (Valdoxan) in the treatment of gambling: A pilot study. In: Neuroscience and Behavioral Physiology. 2017 ; Vol. 47, No. 7. pp. 795–798.

BibTeX

@article{29e8bd711ddd4542bf6e6bf242f2b2be,
title = "The use of agomelatine (Valdoxan) in the treatment of gambling: A pilot study",
author = "A.Yu. Egorov",
year = "2017",
language = "English",
volume = "47",
pages = "795–798",
journal = "Neuroscience and Behavioral Physiology",
issn = "0097-0549",
publisher = "Springer Nature",
number = "7",

}

RIS

TY - JOUR

T1 - The use of agomelatine (Valdoxan) in the treatment of gambling: A pilot study

AU - Egorov, A.Yu.

PY - 2017

Y1 - 2017

M3 - Article

VL - 47

SP - 795

EP - 798

JO - Neuroscience and Behavioral Physiology

JF - Neuroscience and Behavioral Physiology

SN - 0097-0549

IS - 7

ER -

ID: 33210826